As the crisis at Japan’s Fukushima Daiichi nuclear plant continues, some worry that radiation from the damaged reactors will reach U.S. shores. Dr. Edward Maher, president of the Health Physics Society, and an environmental sci…
Johnson & Johnson has issued another recall, and this time, it’s not over a typo. The company’s Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cart…
Japan’s health ministry says it’s continuing its suspension of pediatric vaccines made by Pfizer and Sanofi-Aventis, despite finding no connection between the vaccines and the deaths of four children. Both drugmakers are cooper…
Stem cell research is still too hot for most investors, but NeoStem is starting to change that, thanks to some unexpected events. Among them are the Catholic Church’s surprising embrace of NeoStem’s research and NeoStem’s footh…
The odds of shepherding a new drug to market in recent years has fallen to nearly one in 10 — about half of the previous rate, according to a new study released this week. First, a new treatment must survive several layers of …